Delivery Order SPE2DB24D3013-SPE2DB25FFMSC
- Not listed
- The Defense Logistics Agency awarded a $10,711.89 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orencia 125 mg/ml syringes. The contract carries a firm fixed price structure with no set-aside designation, reflecting competitive procurement procedures. The award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $4,522.89 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on October 17, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Orencia 125 mg/ml syringes valued at $8,000.63. This non-competitive, firm fixed-price delivery order is set to be completed by October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $15,787.66 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes. The contract, which became effective on November 3, 2025, with an ultimate completion date of November 4, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $24,768.44 by the Defense Logistics Agency (DLA) for the supply of Orencia 125 mg/ml syringes. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of December 2, 2025. The place of performance is listed as the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,570.63 on July 14, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, valued at $3,762.90, with an ultimate completion date of December 17, 2025. This non-competitive delivery order is issued under a firm fixed price arrangement and represents a child contract executed against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,013.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Orencia 125 mg/mL syringes. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), carries an ultimate completion date of December 3, 2025, and involves no set-aside designation. Performance will be executed at the company's corporate office location in...
- The Defense Logistics Agency awarded a $13,599.70 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, a pharmaceutical product used in the treatment of autoimmune conditions. The contract is a firm fixed price delivery order with an ultimate completion date of December 29, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. This award utilizes no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes, valued at $3,792.18 with a firm fixed price contract type. This award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations center. This...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMSCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,675.77 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes. This contract, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was made competitively and reflects AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Orencia delivery represents one of numerous orders fulfilled through this prime contract vehicle, which supports customers including the Defense Health Agency and the U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/18/25 |